SK바이오팜

326030KOSPI자연과학 및 공학 연구개발업

53.5 / 100

Reference Date: 2026-07-24

Financial Score22.0 / 40

News Sentiment17.5 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but PBR raises overvaluation concerns. Declined 8.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SK Bios制药 was established in 1993, focusing on innovative drug development for epilepsy and successfully expanding its technology exports to multiple countries, including the U.S. and Europe. Its flagship products, Xenobamate and Solriamfetol, are sold in global markets, with sales reaching 70.67 billion KRW in 2025. The company is also advancing into new therapeutic modalities such as RPT and TPD to expand into oncology.

Number of Employees

272people

Average Salary

109.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

23.38Industry Average 43.646.5Point

Lower than industry avg (good)

PBR

7.55Industry Average 2.520.0Point

3.0x industry avg (risky)

ROE

36.17Industry Average -32.093.5Point

Well below industry avg

Debt Ratio

9.30Industry Average 7.312.0Point

Higher than industry avg (caution)

Trend 2023~202510.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲41.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲234.2% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 25.3% (improving, 3yr)

Detailed News Sentiment

28 totalPositive 15Neutral 11Negative 2Average Sentiment Score 69.8

Positive
"SK바이오팜, 엑스코프리 처방량 증가 이어질 것…목표가 13만원"-i...
SK바이오팜의 뇌전증 신약 엑스코프리 처방량 증가로 인한 성장 전망이 긍정적으로 평가되어 투자의견 매수와 목표주가 상향 조정이 이루어졌다.
Neutral
노바티스, 한국에 방사성의약품 공장 짓는다…복지부와 1400억 투자 협...
노바티스의 국내 방사성의약품 공장 건설 계획은 SK바이오팜과 직접적인 연관성이 없어 중립적 평가.
Neutral
"한국·대만, 바이오 공급망 전략적 파트너, 글로벌 협력 확대해야"
Global collaboration opportunities highlighted for Korean and Taiwanese biotech sectors, but specific impact on SK바이오팜 stock remains unclear.

Detailed Momentum

52-week position1.0Point

Near 52w low (7%, downtrend)

Current 79,700Won52-week high 140,70052-week low 74,600

1-month return1.0Point

1m -7.97% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral단기차입금증가결정2026-06-29